Nobuhito Taniki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Early steroid initiation may improve outcomes in immune checkpoint inhibitor-related cholangitis: a multicenter cohort study.

Early steroid initiation may improve outcomes in immune checkpoint inhibitor-related cholangitis: a multicenter cohort study.

Journal: Immunological medicine

Published: July 06, 2026

A case of portal hypertension associated with a giant hepatic arterioportal fistula successfully treated with partial hepatic arterial embolization.

A case of portal hypertension associated with a giant hepatic arterioportal fistula successfully treated with partial hepatic arterial embolization.

Journal: Clinical journal of gastroenterology

Published: May 01, 2026

Eosinophilic cholangitis mimicking IgG4-related sclerosing cholangitis in an older female patient.

Eosinophilic cholangitis mimicking IgG4-related sclerosing cholangitis in an older female patient.

Journal: Immunological medicine

Published: March 27, 2026

Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study.

Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study.

Journal: Journal of gastroenterology

Published: July 09, 2025

Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort study.

Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort study.

Journal: Frontiers in immunology

Published: June 25, 2025

Trends and Barriers in Liver Transplantation for Patients With Decompensated Cirrhosis: A 15-Year Single-Center Cohort at a Japanese Center.

Trends and Barriers in Liver Transplantation for Patients With Decompensated Cirrhosis: A 15-Year Single-Center Cohort at a Japanese Center.

Journal: Transplantation proceedings

Published: June 02, 2025

The impact of T cells on immune-related liver diseases: an overview.

The impact of T cells on immune-related liver diseases: an overview.

Journal: Inflammation and regeneration

Published: March 21, 2025

Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Cohort Study.

Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Cohort Study.

Journal: Cancer medicine

Published: January 24, 2025

Case review of perivascular epithelioid cell tumor occurring in patients with Li-Fraumeni syndrome.

Case review of perivascular epithelioid cell tumor occurring in patients with Li-Fraumeni syndrome.

Journal: Familial cancer

Published: August 15, 2024

The gut-liver axis in hepatobiliary diseases.

The gut-liver axis in hepatobiliary diseases.

Journal: Inflammation and regeneration

Published: November 01, 2023

Granulocyte-monocyte/macrophage apheresis for steroid-nonresponsive or steroid-intolerant severe alcohol-associated hepatitis: A pilot study.

Granulocyte-monocyte/macrophage apheresis for steroid-nonresponsive or steroid-intolerant severe alcohol-associated hepatitis: A pilot study.

Journal: Hepatology communications

Published: October 18, 2023

Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.

Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.

Journal: Scientific reports

Published: August 14, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026